Allopurinol in Acute Gout

U

Université de Sherbrooke

Status

Withdrawn

Conditions

Gout

Treatments

Drug: allopurinol

Study type

Interventional

Funder types

Other

Identifiers

NCT01775098
Allopurinol in acute gout

Details and patient eligibility

About

The objectives of the present study are to determine if starting treatement of hyperuricemia with allopurinol during an acute gout crises has an impact on the duration or the severity of the crises

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

More than 18 years old Able to sign informed consent Indication of long-term treatment with allopurinol Acute gout crisis

Exclusion criteria

Les than 18 years-old Unable to consent Contra-indication to allopurinol

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

0 participants in 2 patient groups, including a placebo group

Allopurinol
Experimental group
Description:
treatment with allopurinol
Treatment:
Drug: allopurinol
placebo
Placebo Comparator group
Description:
placebo comparator
Treatment:
Drug: allopurinol

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems